Pharma/Biotech Perspectives Track

2019 AER Conference

C10 - A Case-Based Assessment of Post-Trial Access to Investigational Medicines

Speaker(s)

• 

  Karla Childers, MSJ
  

  Senior Director, Strategic Projects, Office of the Chief Medical Officer, Johnson & Johnson
  
• 

  Ariella Kelman, MD
  

  Global Head, Bioethics, Genentech, a member of the Roche Group
  

This session will focus on real world cases that demonstrate the complexity of decision making in providing continued access to investigational medicines after a clinical trial. During this session, speakers and attendees will:

Learning Objectives:

• Share challenges of defining a broadly applicable policy for post-trial access
• Discuss key considerations in making decisions about granting post-trial access
• Provide an understanding of how to apply bioethical principles through real world examples